| 1298492 | BP31_H | Blood pressure QTL 31 (human) | 2.07 | | Blood pressure | systolic | 11 | 34640077 | 123626865 | Human |
| 1357289 | AASTH31_H | Allergic/atopic asthma related QTL 31 (human) | 2 | | Reversible airflow obstruction | | 11 | 40974301 | 81574509 | Human |
| 1357297 | AASTH21_H | Allergic/atopic asthma related QTL 21 (human) | 2 | .002 | Reversible airflow obstruction | post-bronchodilator FEV1 | 11 | 45496349 | 71496349 | Human |
| 1576345 | LVC1_H | Left ventricular contractility QTL 1 (human) | 3.93 | | Left ventricular contractility | | 11 | 16817071 | 70403343 | Human |
| 1559113 | SCL31_H | Serum cholesterol level QTL 31 (human) | 3.72 | | Lipid level | LDL cholesterol | 11 | 28913978 | 70403233 | Human |
| 1559107 | SCL32_H | Serum cholesterol level QTL 32 (human) | 3.27 | | Lipid level | LDL cholesterol | 11 | 28913978 | 70403233 | Human |
| 1559104 | SCL15_H | Serum cholesterol level QTL 15 (human) | 2.6 | .06 | Lipid level | hyperlipidemia susceptibility | 11 | 17086204 | 79965640 | Human |
| 1643317 | BW233_H | Body weight QTL 233 (human) | .86 | | Body weight | body mass index | 11 | 66965521 | 92965521 | Human |
| 2289508 | BW452_H | Body weight QTL 452 (human) | 2.36 | | Body fat amount | abdominal | 11 | 59721888 | 73505325 | Human |
| 2289200 | BW356_H | Body weight QTL 356 (human) | | .0163 | Body fat amount | percent fat | 11 | 60505228 | 86505228 | Human |
| 1643410 | BW281_H | Body Weight QTL 281 (human) | 2.03 | .001 | Body weight | | 11 | 45496349 | 71496349 | Human |
| 1643420 | BW275_H | Body Weight QTL 275 (human) | 2.13 | .0009 | Body weight | | 21 | 66965521 | 92965521 | Human |
| 1643419 | BW274_H | Body Weight QTL 274 (human) | 2.19 | .0008 | Body weight | | 11 | 66965521 | 92965521 | Human |
| 2289174 | SADIPOQ7_H | Serum adiponectin level QTL 7 (human) | 4.2 | | Hormone level | adiponectin level | 11 | 58496495 | 120828264 | Human |
| 2289505 | BW447_H | Body weight QTL 447 (human) | 2.94 | | Body morphometry | waist to hip ratio | 11 | 59721888 | 73505325 | Human |
| 1643405 | BMD9_H | Bone mineral density QTL 9 (human) | 2.64 | .0002 | Bone mineral density | | 11 | 60505228 | 86505228 | Human |
| 1643360 | BW339_H | Body weight QTL 339 (human) | 2 | | Body fat amount | percent body fat | 11 | 60505228 | 86505228 | Human |
| 1643371 | BW329_H | Body weight QTL 329 (human) | 2.64 | .0002 | Body fat amount | | 11 | 60505228 | 86505228 | Human |
| 2292918 | PRSTS142_H | Prostate tumor susceptibility QTL 142 (human) | 6.12 | .000015 | Prostate tumor susceptibility | | 11 | 54893394 | 80893394 | Human |
| 2292942 | PRSTS195_H | Prostate tumor susceptibility QTL 195 (human) | 1.28 | | Prostate tumor susceptibility | | 11 | 54893394 | 80893394 | Human |
| 2293009 | PRSTS194_H | Prostate tumor susceptibility QTL 194 (human) | 1.57 | | Prostate tumor susceptibility | | 11 | 54893394 | 80893394 | Human |
| 2292771 | PRSTS33_H | Prostate tumor susceptibility QTL 33 (human) | | | Prostate tumor susceptibility | early onset | 11 | 60505228 | 86505228 | Human |
| 2292855 | MYI30_H | Myocardial infarction susceptibility QTL 30 (human) | | | Myocardial infarction susceptibility | early-onset | 11 | 66965521 | 92965521 | Human |
| 2292849 | MYI31_H | Myocardial infarction susceptibility QTL 31 (human) | | | Myocardial infarction susceptibility | early-onset | 11 | 66965521 | 92965521 | Human |
| 2292783 | MYI29_H | Myocardial infarction susceptibility QTL 29 (human) | | | Myocardial infarction susceptibility | early-onset | 11 | 43205915 | 69205915 | Human |
| 2300235 | PRSTS358_H | Prostate tumor susceptibility QTL 358 (human) | | .018 | Prostate tumor susceptibility | | 11 | 60505228 | 86505228 | Human |
| 2316704 | GLUCO256_H | Glucose level QTL 256 (human) | 2.98 | .00011 | Glucose level | | 11 | 65876035 | 91876035 | Human |
| 2316064 | GLUCO210_H | Glucose level QTL 210 (human) | | .027 | Glucose level | | 11 | 54893394 | 80893394 | Human |